Please select the option that best describes you:

When do you consider consolidation chest radiation in a patient with stage IV non-small cell carcinoma of the lung who has had good response to systemic therapy?  

Does mutational status (e.g. EGFR mutation) impact your decision?



Answer from: Radiation Oncologist at Academic Institution
Sign In or Register to read more